and Medicine Engineering National Academies of Sciences, Action Collaborative on Countering the U.S. Opioid Epidemic, Health and Medicine Division, Board on Health Care Services, Board on Health Sciences Policy, Clare Stroud (EDT), Sheena M. Posey Norris (EDT), Lisa Bain (EDT) Methadone Treatment for Opioid Use Disorder

Annotation

Methadone is a Food and Drug Administration- (FDA-) approved medication for treating opioid use disorder (OUD), a chronic brain disease that affects more than 2.7 million people in the United States aged 12 and older. Despite its effectiveness in saving lives, many barriers impede access to, initiation of, and retention in methadone treatment for OUD. To address these barriers, on March 3 and 4, 2022, the National Academies of Sciences, Engineering, and Medicine hosted a workshop on "Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws," at the request of the Office of National Drug Control Policy in the Executive Office of the President. This publication summarizes the presentation and discussion of the workshop.